Cargando…

Hepatic arterial chemotherapy for metastatic colorectal carcinoma.

In this review, the rationale of regional chemotherapy for treatment of hepatic metastases in advanced colorectal carcinoma is discussed. Pharmacokinetic principles and early clinical experience of hepatic arterial drug administration are summarised. The regional advantage of fluoropyrimidine compou...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Takats, P. G., Kerr, D. J., Poole, C. J., Warren, H. W., McArdle, C. S.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1994
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968698/ https://www.ncbi.nlm.nih.gov/pubmed/8297738

Ejemplares similares

The pharmacokinetics of 5-fluorouracil administered by arterial infusion in advanced colorectal hepatic metastases.
por: Goldberg, J. A., et al.
Publicado: (1990)

Is there a relationship between regional microsphere distribution and hepatic arterial blood flow?
por: Anderson, J. H., et al.
Publicado: (1992)

Regional chemotherapy for inoperable renal carcinoma: a method of targeting therapeutic microspheres to tumour.
por: Anderson, J. H., et al.
Publicado: (1991)

Duplex/colour Doppler sonography: measurement of changes in hepatic arterial haemodynamics following intra-arterial angiotensin II infusion.
por: Leen, E., et al.
Publicado: (1993)

The use of duplex sonography in the detection of colorectal hepatic metastases.
por: Leen, E., et al.
Publicado: (1991)

A phase II study of regional 5-fluorouracil infusion with intravenous folinic acid for colorectal liver metastases.
por: Warren, H. W., et al.
Publicado: (1994)

A phase I study of regional 5-fluorouracil and systemic folinic acid for patients with colorectal liver metastases.
por: Anderson, J. H., et al.
Publicado: (1992)

Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinoma.
por: McArdle, C. S., et al.
Publicado: (1994)

The relation of ras family oncogene expression to conventional staging criteria and clinical outcome in colorectal carcinoma.
por: Kerr, I. B., et al.
Publicado: (1986)

A pharmacokinetic comparison of intravenous versus intra-arterial folinic acid.
por: Anderson, J. H., et al.
Publicado: (1992)

Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases.
por: Goldberg, J. A., et al.
Publicado: (1988)

Hepatic Cryotherapy and Subsequent Hepatic Arterial Chemotherapy for Colorectal Metastases to the Liver
por: Stubbs, Richard S., et al.
Publicado: (1998)

Hepatic Arterial Infusion Chemotherapy With Folfirinox or Oxaliplatin Alone in Metastatic Colorectal Cancer
por: Randrian, Violaine, et al.
Publicado: (2022)

Isolation and preliminary characterisation of cDNA clones representing mRNAs associated with tumour progression and metastasis in colorectal cancer.
por: Elvin, P., et al.
Publicado: (1988)

Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer
por: Goi, Takanori, et al.
Publicado: (2015)

Clinical correlation of high activity dynamic hepatic scintigraphy in patients with colorectal cancer.
por: Hemingway, D. M., et al.
Publicado: (1992)

Outcome following surgery for colorectal cancer: analysis by hospital after adjustment for case-mix and deprivation
por: McArdle, C S, et al.
Publicado: (2002)

The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer
por: Crozier, J E M, et al.
Publicado: (2006)

Evaluation of a follow-up programme after curative resection for colorectal cancer
por: Howell, J D, et al.
Publicado: (1999)

The impact of young age on cancer-specific and non-cancer-related survival after surgery for colorectal cancer: 10-year follow-up
por: McMillan, D C, et al.
Publicado: (2009)

Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastases.
por: Goldberg, J. A., et al.
Publicado: (1991)

The effect of deprivation and the systemic inflammatory response on outcome following curative resection for colorectal cancer
por: McMillan, D C, et al.
Publicado: (2003)

A phase II study of regional 2-weekly 5-fluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastases.
por: Howell, J. D., et al.
Publicado: (1997)

The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer
por: Canna, K, et al.
Publicado: (2005)

Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival
por: McArdle, Colin S, et al.
Publicado: (2010)

The impact of old age on cancer-specific and non-cancer-related survival following elective potentially curative surgery for Dukes A/B colorectal cancer
por: McMillan, D C, et al.
Publicado: (2008)

A clinical risk score to predict 3-, 5- and 10-year survival in patients undergoing surgery for Dukes B colorectal cancer
por: McMillan, D C, et al.
Publicado: (2010)

Effect of primary tumor side on survival outcomes in metastatic colorectal cancer patients after hepatic arterial infusion chemotherapy
por: Zhang, Hang-Yu, et al.
Publicado: (2018)

The combination of degradable starch microspheres and angiotensin II in the manipulation of drug delivery in an animal model of colorectal metastasis.
por: Carter, R., et al.
Publicado: (1992)

An in vivo assessment of adriamycin-loaded albumin microspheres.
por: Goldberg, J. A., et al.
Publicado: (1992)

Monitoring blood flow to colorectal liver metastases using laser Doppler flowmetry: the effect of angiotensin II.
por: Hemingway, D. M., et al.
Publicado: (1992)

Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer
por: Forrest, L M, et al.
Publicado: (2004)

Regional delivery of microspheres to liver metastases: the effects of particle size and concentration on intrahepatic distribution.
por: Anderson, J. H., et al.
Publicado: (1991)

The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases
por: Al-Shaiba, R, et al.
Publicado: (2004)

Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
por: Chua, W, et al.
Publicado: (2009)

BRAF testing in metastatic colorectal carcinoma and novel, chemotherapy-free therapeutic options
por: Hummel, Michael, et al.
Publicado: (2021)

Arteriovenous shunting in patients with colorectal liver metastases.
por: Goldberg, J. A., et al.
Publicado: (1991)

THE ASSOCIATION BETWEEN PREOPERATIVE CHEMOTHERAPY AND THE PREVALENCE OF HEPATIC STEATOSIS IN HEPATECTOMY FOR METASTATIC COLORECTAL CANCER
por: KALIL, Antonio Nocchi, et al.
Publicado: (2014)

Hepatic Artery Infusion Chemotherapy
por: Tuchmann, A., et al.
Publicado: (1990)

Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drug.
por: Cummings, J., et al.
Publicado: (1986)

Cannot write session to /tmp/vufind_sessions/sess_oup1m0g8uuiqvrne7fl9ol1vd1